Comprehensive Bioinformatics Examination of Variations Between Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma - Top-Institutions - MDSpire

Comprehensive Bioinformatics Examination of Variations Between Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma

  • By

  • Qi Lyu

  • Yanfei Chai

  • Wei Chen

  • Yao Chen

  • Yufei Li

  • October 29, 2025

  • 0 min

Share

Top Institutions in Pathology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Molecular Oncology
    • Bioinformatics

  • #2

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Cancer Genomics
    • Translational Research

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Cancer Genomics
    • Immunotherapy

  • #4

    National Cancer Center Hospital
    National Cancer Center Hospital

    Tokyo, Japan

    Key Differentiators

    • Oncology
    • Esophageal Cancer
    • Molecular Pathology

  • #5

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Cancer Genomics
    • Immunotherapy
    • Bioinformatics

Original Source(s)

Comprehensive Bioinformatics Examination of Variations Between Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma

  • by Qi Lyu, Yanfei Chai, Wei Chen, Yao Chen, Yufei Li

  • October 29, 2025

Related Content

AI in Oncology: Opportunity and Accountability

Editor-in-Chief Beth Faiman discusses how advanced practitioners can use AI tools for scholarly communications, clinical documentation, and research.

SIRT7-mediated deacetylation of XRCC6 at lysine 591 drives breast cancer progression

PLAG1 rearrangement may be an oncogenic driver in a subset of sporadic cardiac myxomas: a case–control study